HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy

The recent approval of clincially effective immune checkpoint inhibitors illustrates the potential of cancer immunotherapy. A challenging task remains the identification of specific targets guiding immunotherapy. Facilitated by technical advances, the direct identification of physiologically relevan...

Descripción completa

Detalles Bibliográficos
Autores principales: Peper, Janet Kerstin, Bösmüller, Hans-Christian, Schuster, Heiko, Gückel, Brigitte, Hörzer, Helen, Roehle, Kevin, Schäfer, Richard, Wagner, Philipp, Rammensee, Hans-Georg, Stevanović, Stefan, Fend, Falko, Staebler, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910750/
https://www.ncbi.nlm.nih.gov/pubmed/27467910
http://dx.doi.org/10.1080/2162402X.2015.1065369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910750/
https://www.ncbi.nlm.nih.gov/pubmed/27467910
http://dx.doi.org/10.1080/2162402X.2015.1065369

Ejemplares similares